Nanocalcium-deficient hydroxyapatite-poly (e-caprolactone)-polyethylene glycol-poly (e-caprolactone) composite...

Current research in tissue engineering seeks to develop scaffolds that support bone regeneration while degrading at a controlled rate. While hydroxyapatite-based composites are known for their osteoconductive properties, their degradation rates and cellular compatibility remain areas of active investigation. Prior studies have demonstrated that calcium-deficient apatite can offer enhanced solubility and bioactivity compared to stoichiometric hydroxyapatite. However, the specific effects of calcium-deficient apatite in composite scaffolds on cell viability and bone formation are not fully understood. This uncertainty drives the need for more detailed studies on the performance of such composites. Researchers have yet to establish a clear link between scaffold composition and in vivo osteogenic outcomes. The gap in understanding how calcium-deficient apatite influences scaffold behavior motivates further exploration. This study aims to address these unresolved questions by evaluating a novel composite material. The findings may contribute to the design of more effective bone tissue engineering scaffolds.

This study aimed to evaluate the biocompatibility, degradation, and osteogenic potential of a composite scaffold made from nano calcium-deficient apatite and a triblock copolymer. The researchers sought to determine whether the composite could support bone regeneration while maintaining structural integrity. A specific focus was placed on comparing the performance of calcium-deficient apatite with that of conventional hydroxyapatite. The motivation for this comparison stems from the known differences in solubility and reactivity between the two apatite forms. The study also aimed to assess the scaffold's ability to support cell growth and mineralization. By using a well-characterized cell line and in vivo implantation, the researchers aimed to provide comprehensive data. The ultimate goal was to determine if this composite could serve as a viable option for bone tissue engineering. The results could inform future scaffold design and clinical applications.

The researchers synthesized a composite material by combining nano calcium-deficient apatite with a triblock copolymer composed of poly(ɛ-caprolactone) and poly(ethylene glycol). The composite scaffolds were fabricated using a method that produced interconnected macropores. Scaffold porosity and pore size were measured using standard imaging techniques. The degradation rate was assessed by monitoring weight loss in phosphate-buffered saline over 70 days. Cell viability was evaluated using MG-63 osteoblast-like cells cultured on the scaffolds for up to five days. Alkaline phosphatase activity was measured as an indicator of early osteogenic differentiation. Histological analysis was conducted on scaffolds implanted into rabbit bone defects. The study compared the performance of calcium-deficient apatite with that of conventional hydroxyapatite in the same polymer matrix.

The composite scaffolds with 40 wt% nano calcium-deficient apatite exhibited a porosity of 75% and macropores averaging 400 μm in size. These scaffolds showed a significantly higher weight-loss ratio compared to those made with conventional hydroxyapatite after 70 days in phosphate-buffered saline. The viability of MG-63 cells was significantly higher on the calcium-deficient apatite scaffolds at both three and five days. Alkaline phosphatase activity was also higher on the calcium-deficient apatite scaffolds at seven days. Histological evaluation revealed enhanced new bone formation in rabbit bone defects when the calcium-deficient apatite scaffolds were used. The results suggest that the calcium-deficient apatite composite degrades more rapidly than the hydroxyapatite composite. The higher cell viability and alkaline phosphatase activity indicate better osteogenic potential. The in vivo data support the hypothesis that the calcium-deficient apatite enhances bone regeneration.

The study found that the calcium-deficient apatite composite scaffolds exhibited greater degradation rates than the conventional hydroxyapatite scaffolds. The researchers observed higher cell viability and alkaline phosphatase activity in the calcium-deficient apatite group. Histological results confirmed that the calcium-deficient apatite scaffolds supported more new bone formation in vivo. These findings suggest that the composite has good biocompatibility and osteogenic potential. The authors propose that the enhanced degradation and cellular response make the material suitable for bone tissue engineering. The study highlights the advantages of using calcium-deficient apatite over conventional hydroxyapatite in composite scaffolds. The results support the use of this material in future scaffold designs for bone regeneration. The authors suggest that further research is needed to optimize scaffold properties for clinical applications.